Mergers & Acquisitions ·
Clearmind Medicine agrees to acquire a 51% stake in Charging Robotics for $2.5 million
CMNDClearmind Medicine Inc.
On August 31, 2026, Clearmind Medicine Inc. entered into a definitive agreement to acquire a 51% controlling stake in Charging Robotics Ltd., an Israeli developer of wireless charging systems for automated parking and autonomous vehicles, for $2.5 million ($16,778 per share). The transaction is expected to close during the week of September 7, 2026, subject to customary conditions. As a condition to closing, Clearmind will provide Charging Robotics with a $1.5 million loan bearing 4.0% simple annual interest, due on the third anniversary unless extended based on cash flow performance. This strategic acquisition expands Clearmind's operations beyond its core business into the electric vehicle infrastructure sector.